{"id":20576,"date":"2026-06-12T22:15:00","date_gmt":"2026-06-12T20:15:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=38099963ee36eb027138fc9d6086851e"},"modified":"2026-06-12T22:15:00","modified_gmt":"2026-06-12T20:15:00","slug":"glancy-prongay-wolke-rotter-llp-a-leading-securities-fraud-law-firm-encourages-adma-biologics-inc-adma-shareholders-to-inquire-about-securities-fraud-class-action","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=20576","title":{"rendered":"Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages ADMA Biologics, Inc. (ADMA) Shareholders To Inquire About Securities Fraud Class Action"},"content":{"rendered":"

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP<\/a>, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA Biologics, Inc. (\u201cADMA\u201d or the \u201cCompany\u201d) (NASDAQ: ADMA<\/a>) securities between August 9, 2024 and March 25, 2026<\/b>, inclusive (the \u201cClass Period\u201d). ADMA investors have until August 10, 2026 <\/b>to file a lead plaintiff motion.<\/p><\/a><\/a>

\nIF YOU SUFFERED A LOSS ON YOUR ADMA BIOLOGICS, INC. (ADMA) INVESTMENTS, CLICK <\/b>HERE<\/b><\/a> TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS<\/b><\/p>

\nWhat Happened?<\/b><\/p>

\nOn March 24, 2026, Culper Research published a report alleging \u201cChannel Stuffing, an Undisclosed Related Party Distributor, and \u20133% Real Growth in 2025 vs. +20% Reported.\u201d Among other things, the report stated that \u201ctwo high-level employees at one of ADMA's two largest distributors,\u201d had confirmed independently that \u201cstarting in 2025, ADMA induced the distributor to stock excess ASCENIV by offering rebates and extended payment terms in order to meet order expectations. Distributors take unwanted product without having to pay for it, ADMA books the revenues, and reports growth that was never there<\/b>.\u201d<\/p>

\nOn this news, ADMA\u2019s stock price fell $3.96, or 29.1%, over two consecutive trading days to close at $9.63 per share on March 25, 2026, thereby injuring investors.<\/p>

\nWhat Is The Lawsuit About?<\/b><\/p>

\nThe complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, as well as failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) ADMA engaged in an undisclosed related party transaction; (2) ADMA used channel stuffing to create an appearance of revenue; (3) ADMA lacked adequate internal controls; and (4) as a result, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis at all relevant times.<\/p>

\nIf you purchased or otherwise acquired ADMA securities during the Class Period, you may move the Court no later than August 10, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.<\/b><\/p>

\nContact Us To Participate or Learn More:<\/b><\/p>

\nIf you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:\nCharles Linehan, Esq.,\nGlancy Prongay Wolke & Rotter LLP,\n1925 Century Park East, Suite 2100,\nLos Angeles California 90067\nEmail: shareholders@glancylaw.com<\/a>Telephone: 310-201-9150,\nToll-Free: 888-773-9224\nVisit our website at www.glancylaw.com<\/a>.\nFollow us for updates on LinkedIn<\/a>, Twitter<\/a>, or Facebook<\/a>.<\/p>

\nIf you inquire by email, please include your mailing address, telephone number and number of shares purchased.<\/p>

\nTo be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class.<\/p>

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p> Contacts<\/b>

\nContact Us:<\/b>Glancy Prongay Wolke & Rotter LLP,\n1925 Century Park East, Suite 2100\nLos Angeles, CA 90067\nCharles Linehan<\/b>Email: shareholders@glancylaw.com<\/a>Telephone: 310-201-9150\nToll-Free: 888-773-9224\nVisit our website at: www.glancylaw.com<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ADMA B…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-20576","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/20576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20576"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/20576\/revisions"}],"predecessor-version":[{"id":20577,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/20576\/revisions\/20577"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}